<?xml version="1.0" encoding="UTF-8"?>
<ref id="B123-pharmaceutics-12-00171">
 <label>123.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Milovanovic</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Arsenijevic</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Milovanovic</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kanjevac</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Arsenijevic</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Nanoparticles in Antiviral Therapy</article-title>
  <source>Antimicrobial Nanoarchitectonics</source>
  <publisher-name>Elsevier</publisher-name>
  <publisher-loc>Amsterdam, The Netherlands</publisher-loc>
  <year>2017</year>
  <fpage>383</fpage>
  <lpage>410</lpage>
  <isbn>978-0-323-52733-0</isbn>
 </element-citation>
</ref>
